AMANDA BROOKS: Open Payments
NPI 1902443039 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$761 in 29 payments from 17 companies in 2025. Trend: 2023 $888 · 2024 $761 · 2025 $761
Food & beverage: $761
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $170 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Novo Nordisk Inc | 5 | $93 |
| Noven Therapeutics, LLC | 4 | $65 |
| Lilly USA, LLC | 3 | $48 |
| GlaxoSmithKline, LLC. | 1 | $33 |
| Smith+Nephew, Inc. | 1 | $32 |
| Amgen Inc. | 1 | $25 |
| Fresenius USA Marketing, Inc. | 1 | $25 |
| Seqirus USA Inc | 1 | $24 |
Products named: VOQUEZNA, AIRSUPRA, Ozempic, Xelstrym, MOUNJARO, TRELEGY ELLIPTA, PICO, OTEZLA.
Industry payments across GA — which companies pay providers there.
